packageFutibatinib

futibatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Futibatinib is an anticancer kinase inhibitor used to treat cholangiocarcinoma. It is an approved medicine, with one product authorised in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q76791462 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:futibatinib
ATC codes:L01EN04
DrugBank:DB15149
PubChem CID:71621331
Wikidata:Q76791462
formula:C22H22N6O3
molar mass:418.457 g/mol (PubChem CID 71621331)
logP:2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown